Table 3.
Comparison of patient’s characteristics between type 1a and 1b angiectasias
| Patient characteristics | Angioectasia | P-value | |
|---|---|---|---|
| Type 1a (n = 35) | Type 1b (n = 29) | ||
| Sex | |||
| Male | 22 | 17 | n.s |
| Female | 13 | 12 | |
| Age (years) | |||
| Mean ± SD | 69.3 ± 16.4 | 73.5 ± 10.8 | n.s |
| Median (range) | 75 (27–87) | 78 (42–86) | |
| < 65 | 12 | 6 | n.s |
| ≧65 | 23 | 23 | |
| OGIB type | |||
| Occult | 9 | 6 | n.s |
| Overt | 26 | 23 | |
| Drug use | |||
| Antithrombotic | |||
| Yes | 10 | 10 | n.s |
| No | 25 | 19 | |
| NSAIDS | |||
| Yes | 3 | 3 | n.s |
| No | 32 | 26 | |
| Underlying disease | |||
| Cerebrovascular disease | |||
| Yes | 3 | 3 | n.s |
| No | 32 | 26 | |
| Cardiovascular disease | |||
| Yes | 14 | 13 | n.s |
| No | 21 | 16 | |
| Chronic renal failure | |||
| Yes | 3 | 3 | n.s |
| No | 32 | 26 | |
| Hypertension | |||
| Yes | 18 | 19 | n.s |
| No | 17 | 10 | |
| Dyslipidemia | |||
| Yes | 4 | 5 | n.s |
| No | 31 | 24 | |
| Diabetes | |||
| Yes | 7 | 7 | n.s |
| No | 28 | 22 | |
| Liver cirrhosis | |||
| Yes | 8 | 7 | n.s |
| No | 27 | 22 | |
Abbreviations: OGIB obscure gastrointestinal bleeding; NSAIDS nonsteroidal anti-inflammatory drugs